Success Metrics

Clinical Success Rate
90.5%

Based on 19 completed trials

Completion Rate
90%(19/21)
Active Trials
4(13%)
Results Posted
21%(4 trials)
Terminated
2(6%)

Phase Distribution

Ph not_applicable
3
9%
Ph phase_2
3
9%
Ph phase_3
1
3%
Ph phase_4
21
66%
Ph early_phase_1
2
6%
Ph phase_1
1
3%

Phase Distribution

3

Early Stage

3

Mid Stage

22

Late Stage

Phase Distribution31 total trials
Early Phase 1First-in-human
2(6.5%)
Phase 1Safety & dosage
1(3.2%)
Phase 2Efficacy & side effects
3(9.7%)
Phase 3Large-scale testing
1(3.2%)
Phase 4Post-market surveillance
21(67.7%)
N/ANon-phased studies
3(9.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

86.4%

19 of 22 finished

Non-Completion Rate

13.6%

3 ended early

Currently Active

4

trials recruiting

Total Trials

32

all time

Status Distribution
Active(4)
Completed(19)
Terminated(3)
Other(6)

Detailed Status

Completed19
unknown6
Recruiting4
Terminated2
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
32
Active
4
Success Rate
90.5%
Most Advanced
Phase 4

Trials by Phase

Early Phase 12 (6.5%)
Phase 11 (3.2%)
Phase 23 (9.7%)
Phase 31 (3.2%)
Phase 421 (67.7%)
N/A3 (9.7%)

Trials by Status

recruiting413%
unknown619%
terminated26%
withdrawn13%
completed1959%

Recent Activity

Clinical Trials (32)

Showing 20 of 32 trialsScroll for more
NCT06977841Not Applicable

Tegoprazan-Based Therapies for H. Pylori Eradication: A Randomized Controlled Trial

Completed
NCT02754583Phase 3

Sanitation, Water, and Instruction in Face-washing for Trachoma I/II

Completed
NCT07139366Phase 4

Saccharomyces Boulardii Combined With Bismuth Quadruple Therapy for Helicobacter Pylori Rescue Treatment

Recruiting
NCT05874544Phase 4

Rescue Therapy for Helicobacter Pylori Infection

Completed
NCT06225570Early Phase 1

Weekly Isotretinoin vs Tetracycline for Moderate Acne

Recruiting
NCT06168084Phase 4

Helicobacter Rescue Therapy With Vonorazon and Amoxicillin Dual Therapy Versus Bismuth-containing Quadruple Therapy

Completed
NCT01880515Phase 2

Tetracycline as a Prophylaxis for Rash in Patients With NSCLC Receiving Treatment With BIBW2992 (Afatinib)

Completed
NCT05874570Phase 4

Doxycycline for Helicobacter Pylori Rescue Treatment

Recruiting
NCT05049902Phase 4

Bismuth-containing Quadruple Therapy for Helicobacter Pylori Eradication

Completed
NCT02359331Not Applicable

The Efficacy of the 7 Days Tailored Therapy as 2nd Rescue Therapy for Eradication of H. Pylori Infection

Terminated
NCT04678492Phase 4

Helicobacter Rescue Therapy With High-dose Esomeprazole and Amoxicillin Dual Therapy Versus Bismuth-containing Quadruple Therapy

Completed
NCT05250050Phase 4

Susceptibility-Guided Therapy for Helicobacter Pylori Infection Treatment

Unknown
NCT05061732Phase 4

Helicobacter Pylori Eradication and Follow-up

Recruiting
NCT05018923Phase 4

Tetracycline Versus Doxycycline for HP Rescue Therapy

Unknown
NCT04901117Phase 4

Bismuth-containing Quadruple Therapy for Helicobacter Pylori Eradication: A Randomized Clinical Trial of 10 and 14 Days

Unknown
NCT03708848Phase 4

Tailored Therapy for Helicobacter Pylori Treatment in Patients With Penicillin Allergy

Completed
NCT03609892Phase 4

Helicobacter Rescue Therapy With Berberine Plus Amoxicillin Quadruple Therapy Versus Tetracycline Plus Furazolidone Quadruple Therapy

Completed
NCT04066257Phase 1

Evaluate the PK of Multiple Oral Doses of Tegoprazan, Metronidazole, Tetracycline and Bismuth in Healthy Volunteers

Completed
NCT02159976Not Applicable

Compare Sequential and Quadruple Therapy for the Eradication of Helicobacter Pylori in Korea

Completed
NCT02576652Phase 4

Bone Histomorphometry in Postmenopausal Men and Women With Osteoarthritis Undergoing Total Hip Replacement

Completed

Drug Details

Intervention Type
DRUG
Total Trials
32